ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

OVID Ovid Therapeutics Inc

3.29
0.09 (2.81%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Ovid Therapeutics Inc OVID NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.09 2.81% 3.29 13:00:10
始値 安値 高値 終値 前日終値
3.16 3.12 3.31 3.29 3.20
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0805:22EDGAR2Form 8-K - Current report
2024/5/1506:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/5/1421:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1421:03EDGAR2Form 8-K - Current report
2024/5/1421:00GLOBEOvid Therapeutics Reports Business Updates and First Quarter..
2024/5/1320:00GLOBEOvid Therapeutics to Present at the H.C. Wainwright 2nd..
2024/4/0421:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
2024/3/0822:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0822:20EDGAR2Form 8-K - Current report
2024/3/0822:00GLOBEOvid Therapeutics Reports Business Updates, Fourth Quarter..
2024/2/2822:00GLOBEOvid Therapeutics to Present at the TD Cowen 44th Annual..
2024/2/2708:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2708:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2707:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2707:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1501:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1220:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0622:00GLOBEOvid Therapeutics to Present at the Oppenheimer 34th Annual..
2023/12/0707:08EDGAR2Form 8-K - Current report
2023/12/0121:30GLOBEOvid Therapeutics to Present Five Abstracts Supporting its..
2023/11/1614:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1606:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0405:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0321:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0321:10EDGAR2Form 8-K - Current report
2023/11/0321:00GLOBEOvid Therapeutics Reports Third Quarter 2023 Financial..
2023/10/1821:04EDGAR2Form 8-K - Current report
2023/10/1821:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
2023/10/1021:00GLOBEOvid Therapeutics to Present at the Jefferies Biotech..
2023/10/0301:15EDGAR2Form 8-K - Current report
2023/9/2620:30GLOBEOvid Therapeutics to Host Investor Event - R&D Day on..
2023/9/2020:30GLOBEOvid Therapeutics to Present at the 2023 Cantor Fitzgerald..
2023/8/3021:00GLOBEOvid Therapeutics to Participate in Upcoming September..
2023/8/0422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0422:10EDGAR2Form 8-K - Current report
2023/8/0421:00GLOBEOvid Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0121:00GLOBEOvid Therapeutics to Present at the BTIG Virtual..
2023/8/0106:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/6/2821:00GLOBEOvid Therapeutics Expands Its Scientific Leadership Team &..
2023/6/2621:00GLOBEOvid Therapeutics Added to Russell 3000® Index

最近閲覧した銘柄

Delayed Upgrade Clock